MyofascialPainSyndromeandItsSuggestedRoleinthePathogenesisandTreatmentofFibromyalgiaSyndrome

Myofascial pain syndrome (MPS) is one of the most common disorders encountered in clinical pain practice, yet it is often overlooked by physicians. MPS is characterized by chronic muscle pain accompanied by myofascial trigger points (MTrPs) — specific areas of hyperirritability in muscles that produce local and referred pain in reproducible patterns. The failure to recognize MPS leads to over-investigation, unnecessary medical interventions, and serious cost implications. This review explores the relationship between MPS and fibromyalgia syndrome (FMS), examining how these conditions may share common pathophysiologic mechanisms.

The author conducted a comprehensive review of the literature on myofascial pain syndrome, examining its epidemiology, diagnostic criteria, pathophysiology, and relationship to fibromyalgia. The review synthesized clinical evidence and research findings from multiple studies to present current understanding of trigger point mechanisms and optimal treatment approaches. The analysis included examination of prevalence studies, diagnostic criteria validation, electromyographic findings, and various treatment modalities including trigger point injection therapy, physical therapy, and pharmacological management.

MPS affects women more than men (3:1 ratio) and is the most common cause of chronic regional pain, including shoulder pain, chronic back pain, and headaches. Studies showed MTrPs were present in 54% of patients with chronic head and neck pain, and in 74% of patients at community pain centers. Importantly, approximately 70% of patients with fibromyalgia also have MTrPs, suggesting significant overlap between conditions. The review revealed that trigger points are likely located near dysfunctional motor endplates and that nociceptive input from untreated trigger points may induce central sensitization, potentially leading to widespread pain and fibromyalgia development.

Trigger point injection therapy showed effectiveness when performed correctly by skilled practitioners, with pain relief lasting months when perpetuating factors are addressed.

This research suggests that myofascial pain syndrome may play a crucial role in the development of fibromyalgia through central sensitization mechanisms. Early recognition and proper treatment of MPS could potentially prevent the progression to widespread chronic pain syndromes. For patients, this means that effective treatment exists for localized trigger point pain, and addressing these issues promptly may prevent more complex chronic pain conditions. For clinicians, the findings emphasize the importance of developing skills in trigger point examination and treatment, as well as understanding the multidimensional approach needed for optimal management including trigger point injections, physical therapy, and addressing perpetuating factors.